With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...

July 13, 2026 • The U.S. and Iran exchanged fire over the weekend amid tensions over the Strait of Hormuz. And, Congress returns from recess facing tight deadlines.